Steris (STE) reported fiscal Q2 adjusted earnings late Wednesday of $2.14 per diluted share, up from $1.86 a year earlier.

Analysts polled by Capital IQ expected $2.13.

Revenue for the quarter ended Sept. 30 rose to $1.33 billion from $1.24 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.33 billion.

For fiscal 2025, the company continues to expect adjusted EPS of $9.05 to $9.25 and revenue growth of 6.5% to 7.5%.

The consensus is for normalized EPS of $9.16.